Business | NDTV Profit Team | Thursday February 4, 2016
Top drug makers, including Wockhardt, Lupin and Cipla, came under a sharp selloff on Thursday following a news report saying the US government has made it mandatory for active pharmaceutical ingredients (APIs) to be manufactured locally.
www.ndtv.com/business